• 1
    Nelson DR. The immunopathogenesis of hepatitis C virus infection. Clin Liver Dis 2001; 5:931953.
  • 2
    Bertoletti A, Maini MK. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection. Curr Opin Immunol 2000; 12:403408.
  • 3
    Patel T, Gores GJ. Apoptosis and hepatobiliary disease. Hepatology 1995; 21:17251741.
  • 4
    Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, et al. Fas and perforin pathways as major mechanisms of T-cell mediated cytotoxicity. Science 1994; 265:528530.
  • 5
    Shi L, Kraut RP, Aebersold R, Greenberg AH. A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J Exp Med 1992; 175:553566.
  • 6
    Chisari FV. Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis. Curr Top Microbiol Immunol 1996; 206:149173.
  • 7
    Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of hepatitis b virus by cytotoxic T lymphocytes. Immunity 1996; 4:2536.
  • 8
    Guidotti LG, Borrow P, Brown A, McClary H, Koch R, Chisari FV. Noncytopathic clearance of lymphocyte choriomeningitis virus from the hepatocyte. J Exp Med 1999; 189:15551564.
  • 9
    Koziel MJ, Dudley D, Afdhal N, Choo QL, Houghton M, Ralston R, Walker BD. Hepatitis C virus-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 1993; 67:75227532.
  • 10
    Rehermann B, Chang K, McHutchinson J, Kokka R, Houghton M, Rice CM, Chisari FV. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 1996; 70:70927102.
  • 11
    Pestka S, Langer JA, Zoon KC, Samuel CE. Interferons and their actions. Ann Rev Biochem 1987; 56:727777.
  • 12
    Nuti S, Rosa D, Valiante NM, Saletti G, Caratozzolo M, Dellabona P, Barnaba V, et al. Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for V alpha 24 T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol 1998; 28:34483455.
  • 13
    Huang L, Fowler N, Schmidt EV, Koziel M. Enhanced apoptosis of activated T cells induced by hepatocytes expressing HCV structural proteins [Abstract]. Hepatology 2000; 32(Part 2):303A.
  • 14
    Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science 2000; 290:19721974.
  • 15
    Lohmann V, Koch JO, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999; 285:110113.
  • 16
    Guo JT, Bichko VV, Seeger C. Effect of alpha interferon on the hepatitis C virus replicon. J Virol 2001; 75:85168523.
  • 17
    Lauer GM, Ouchi K, Chung RT, Nguyen TN, Day CL, Purkis DR, Reiser M, et al. Comprehensive analysis of CD8+ T-cell response against hepatitis C virus reveals multiple unpredicted specificities. J Virol 2002; 76:61046113.
  • 18
    Fang JWS, Gonzalez-Peralta RP, Gottschall JA, Davis GL, Gish RG, Wu PC, Lau JYN, et al. Hepatic expression of c-Fas and apoptosis in chronic hepatitis C virus infection [Abstract]. Hepatology 1994; 20:250A.
  • 19
    Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H, et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 1994; 19:13541359.
  • 20
    Von Reyher U, Strater J, Kittstein W, Gschwendt M, Krammer PH, Moller P. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. Cancer Res 1998; 58:526534.
  • 21
    Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999; 284:825829.
  • 22
    Frese M, Schwarzle V, Barth K, Krieger N, Lohmann V, Mihm S, Haller O, et al. Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 2002; 35:694703.
  • 23
    Zhu H, Zhao H, Collins CB, Eckenrode SE, Run Q, McIndoe RA, et al. Gene expression associated with IFNα antiviral activity in a HCV replicon cell line. Hepatology (in press).
  • 24
    Glue P, Fang J, Sabo R, Rouzier-Panis R, Raffanel C, Gupta SK, Garaud JJ, et al. Peg-interferon-α-2b: pharmacokinetics, safety and preliminary efficacy data [Abstract]. Hepatology 1999; 30(Part 2):189A.
  • 25
    Tu Z, Xu YL, Zhu H, Soldevila-Pico C, Rosen H, Hemming A, Liu C, et al. Phenotypic and functional characterization of innate and HCV-specific T cells from liver, peri-hepatic lymph nodes, and peripheral blood suggest antigen presentation within the lymph node, cytokine mediated antiviral activity, and effector cell apoptosis within the liver [Abstract]. Hepatology 2002; 36(Part 2):267A.
  • 26
    Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GMA, Papagno L, Ogg GS, et al. Memory CD8+T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8:379385.
  • 27
    Koziel M. Fas-FasL and T-cell apoptosis in HCV transgenic mice [Abstract]. Hepatic Inflammation and Immunity 2002, March 21–24, 2002, Galveston, Texas, p. 30.
  • 28
    Hahn CS, Cho YG, Kang BS, Lester IM, Hanh YS. The HCV core protein acts as a positive regulator of Fas-mediated apoptosis in a human lymphoblastoid T cell line. Virology 2000; 276:127137.